Navigation Links
Major Gene Study Uncovers Secrets of Leukemia

nts with ALL had deletions or mutations in one of three so-called "master genes" that control the normal differentiation of immature progenitor cells into mature B lymphocytes. In ALL, the leukemic cells fail to differentiate normally and remain blocked at an immature stage of development. Locked in this state, the leukemic cells continue to proliferate, and this continual growth of leukemic cells eventually kills the child. The mutations identified in three genes, "PAX5," "EBF" and "Ikaros," are likely to directly contribute to this block in normal lymphocyte differentiation.

"The more we learn about why progenitor cells get stuck in the primitive, cancerous stage, the more likely we'll be able to design new therapies that eliminate them. That could help us continue our successful efforts to increase the survival rate of ALL," said Ching-Hon Pui, M.D., chair of the Oncology department and American Cancer Society Professor at St. Jude. Pui co-authored the paper.

The other authors of this paper include William E. Evans, Mary V. Relling, Charles G. Mullighan, Salil Goorha, Ina Radtke, Christopher B. Miller, Elaine Coustan-Smith, James D. Dalton, Kevin Girtman, Susan Mathew, Jing Ma, Stanley B. Pounds, Xiaoping Su and Sheila A. Shurtleff.

This work was supported in part by the National Cancer Institute, the National Institute of General Medical Sciences, the National Health and Medical Research Council (Australia), the Royal Australasian College of Physicians, the Haematology Society of Australia and New Zealand, and ALSAC.

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is internationally recognized for its pioneering work in finding cures and saving children with cancer and other catastrophic diseases. Founded by late entertainer Danny Thomas and based in Memphis, Tenn., St. Jude freely shares its discoveries with scientific and medical communities around the world. No family ever pays for treatments not
'"/>




Page: 1 2 3

Related medicine technology :

1. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
2. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
3. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
4. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
5. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
6. Major Manufacturer of Unapproved and Adulterated Drugs
7. Exforge Helps Vast Majority of Patients Effectively Control Their Blood Pressure After Failing on Other Medicines, According to New Clinical Data
8. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
9. Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
10. Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C
11. New Clinical Data for Cytogens Quadramet and Prostacint to be Reported at Upcoming Major Medical Meetings

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Major Gene Study Uncovers Secrets Leukemia
(Date:12/3/2009)...N, Del., Dec. 3 ParagonRx, a Delaw...isk management and optimal medication use, will ho...,s draft guidance on REMS - Risk Evaluation Mitiga...REMS lifecycle management. Dr. Gary Slatko, chief...S and risk management programs, will lead the one-...
(Date:12/3/2009)...., Dec. 3 In response t...ormation technologies in the evolving healthcare d... Center for Health Informatics (DCHI) to provide a...ersee an innovative interdisciplinary approach to ...ysicians, nurses and healthcare administrators wit...
(Date:12/3/2009)...E, Tenn., Dec. 3 Cumber...ced today that data from a recent clinical trial f...avenous treatment for pain and fever, will be pres...m Pharmacists (ASHP) Midyear Clinical Meeting in L... will be displayed in a poster presentation on Mon...
Breaking Medicine Technology:Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting 2New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting 3JNCI news brief 3A Antibody linked to chemotherapy drug inhibits ovarian cancer in lab 53165 1Its Still Too Early to Be Popping Champagne Corks Expert to Comment on Health Care Reform House Healthcare Proposal 53160 1Its Still Too Early to Be Popping Champagne Corks Expert to Comment on Health Care Reform House Healthcare Proposal 53160 2Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2009 Earnings Release Date and Teleconference 53155 1Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2009 Earnings Release Date and Teleconference 53155 2
...Data Presented at Leading Influenza Conference , H...sed,pre-clinical data showing how a new flu vaccin... of influenza, including pandemic and,annual, was ...or,the Control of Influenza VI (Options) Conferenc... which will be published in the,European Journal o...
...tudy Fails to Meet Primary Endpoint of Improvement... 2007 /PRNewswire-FirstCall/ --,Allos Therapeutics...H, the Company,s pivotal Phase 3 study of Efaproxy...y (WBRT) in women,with brain metastases originatin...its primary endpoint of demonstrating a,statistica...
Other Medicine Technology:New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 5Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 2Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 3Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 4Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 5Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 6
(Date:12/4/2009)... Vaccinated children less likely to get herpes zos...4 (HealthDay News) -- Children who are vaccinated ...tion against shingles, new findings suggest. , ...72,163 children in southern California who were va...between 2002 and 2008. , Over an average of 2.5...
(Date:12/4/2009)..., , BOSTON and HOUSTON, Dec. 4 /P...#901-- Cyberonics, Inc . (Nasdaq: CYBX ) announc...py , the only FDA-approved implantable medical dev... be featured in 14 presentations at the American ...lace December 4-8 at the Hynes Convention Center i...
(Date:12/4/2009)..., Plantar fasciitis heel ... Stated each year, and cold therapy has been cited... an effective treatment option. In response to th...lection of compressive cold therapy systems for pl...ine of combination night splint therapies. , ...
(Date:12/3/2009)..., Chiropractic Traffic ha...giving away a very popular marketing tool. $1 gets...ng on steriods. Chiropractic Traffic is even incl...ost. , (PRWEB) December 3... a brand new Email marketing tool. Chiropractic M...
(Date:12/3/2009)..., , MINNEAPOLIS, Dec. 3 ...been named a recipient of the 2009 Leapfrog Top Ho...nized for delivering care that is among the best i...ls of efficiency. ,, The Leapfrog survey is the...key issues including mortality rates for common pr...
Breaking Medicine News(10 mins):Health News:NYU Langone Medical Center Study Shows VNS Therapy is a Safe and Effective Treatment for Refractory Epilepsy 2Health News:NYU Langone Medical Center Study Shows VNS Therapy is a Safe and Effective Treatment for Refractory Epilepsy 3Health News:Orthotics And Beyond Introduces Compressive Cold Therapy Products for Plantar Fasciitis Treatment 2Health News:New Chiropractic Marketing: A $1 Chiropractic Marketing Tool that Can Make Users $1000s 2Health News:Children's Hospitals and Clinics of Minnesota Receives National Recognition for Quality and Efficiency 2
...TISTS WILL CONVENE TO SHARE CUTTING,EDGE RESEARCH ...OWN, W.Va., Aug. 26 On October 16th,2008, the new...Institute,(BRNI) located on the campus on West Vir... research on Alzheimer,s disease,and other memory ...
...xplain what causes the baggy lower eyelids that co... that fat expansion in the eye socket is the prima...xcision should be a component of treatment for pat...tive Surgery , is the first to examine the anatomy...
...ew provided information on the top traumatic brain...e United States as the International Brain Injury ... currently living with the condition. Researchers ...WEB) August 26, 2008 -- LegalView, the most compre...
...Information Offers Single Authoritative, Source o...to Indonesia,s Generics and AP...hua-PRNewswire/ -- Indonesia,s generics,and API (A...s of Thomson Reuters, the world,s leading source o...
...Newswire-FirstCall/ -- Mindray,Medical Internation...facturer,and marketer of medical devices in China,...s converted from Chinese Renminbi to U.S. Dollars....ly, Mindray has issued these historical financial ...
...lly ill rodents with type 1 diabetes have been res...substance other than insulin by scientists at UT S...y of insulin in 1922, type 1 diabetes (insulin-dep...estern researchers, which appear online and in a f...
Other Medicine News:Health News:Pioneering Neurosciences Institute Sets Date for Dedication of New Facility and First-Ever International Forum on Memory and Memory Disorders 2Health News:Pioneering Neurosciences Institute Sets Date for Dedication of New Facility and First-Ever International Forum on Memory and Memory Disorders 3Health News:Why do eyelids sag with age? UCLA study answers mystery 2Health News:LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI 2Health News:LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI 3Health News:LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI 4Health News:Indonesia's Pharmaceutical companies Get Boost in Competitive Advantage from Launch of Newport Horizon Premium and IDRAC Solutions by Thomson Reuters 2Health News:Indonesia's Pharmaceutical companies Get Boost in Competitive Advantage from Launch of Newport Horizon Premium and IDRAC Solutions by Thomson Reuters 3Health News:Mindray Releases Historical Financial Results Converted into US Dollar Terms 2Health News:UT Southwestern scientists discover leptin can also aid type 1 diabetics 2Health News:UT Southwestern scientists discover leptin can also aid type 1 diabetics 3
...ghly effective surgical alternative for the treatm...s positioned close to the high pressure zone of th...ree support of the urethra in the correct position...es, with minimal tissue dissection. Clinical studi...
...s, the PeaceKeeper 20 gauge multi-modality intraoc...Field comprehensive family of lightweight Eraser b... Combining highly effective bipolar hemostasis wit... in a single use, sterile instrument, the PeaceKee...
SUR-FIT® AutoLock® Urostomy Pouch with Accuseal® Tap
SUR-FIT Natura® Urostomy Pouch
Medicine Products: